These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 28747729)
1. Conformational preludes to the latency transition in PAI-1 as determined by atomistic computer simulations and hydrogen/deuterium-exchange mass spectrometry. Petersen M; Madsen JB; Jørgensen TJD; Trelle MB Sci Rep; 2017 Jul; 7(1):6636. PubMed ID: 28747729 [TBL] [Abstract][Full Text] [Related]
2. Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry. Trelle MB; Dupont DM; Madsen JB; Andreasen PA; Jørgensen TJ ACS Chem Biol; 2014 Jan; 9(1):174-82. PubMed ID: 24138169 [TBL] [Abstract][Full Text] [Related]
3. Protein conformational change delayed by steric hindrance from an N-linked glycan. Bager R; Johansen JS; Jensen JK; Stensballe A; Jendroszek A; Buxbom L; Sørensen HP; Andreasen PA J Mol Biol; 2013 Aug; 425(16):2867-77. PubMed ID: 23702291 [TBL] [Abstract][Full Text] [Related]
4. Local transient unfolding of native state PAI-1 associated with serpin metastability. Trelle MB; Madsen JB; Andreasen PA; Jørgensen TJ Angew Chem Int Ed Engl; 2014 Sep; 53(37):9751-4. PubMed ID: 25049220 [TBL] [Abstract][Full Text] [Related]
5. Hydrogen/deuterium exchange mass spectrometry reveals specific changes in the local flexibility of plasminogen activator inhibitor 1 upon binding to the somatomedin B domain of vitronectin. Trelle MB; Hirschberg D; Jansson A; Ploug M; Roepstorff P; Andreasen PA; Jørgensen TJ Biochemistry; 2012 Oct; 51(41):8256-66. PubMed ID: 22957734 [TBL] [Abstract][Full Text] [Related]
6. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790 [TBL] [Abstract][Full Text] [Related]
7. The length of the reactive center loop modulates the latency transition of plasminogen activator inhibitor-1. Na YR; Im H Protein Sci; 2005 Jan; 14(1):55-63. PubMed ID: 15576554 [TBL] [Abstract][Full Text] [Related]
8. Copper(II) Ions Increase Plasminogen Activator Inhibitor Type 1 Dynamics in Key Structural Regions That Govern Stability. Bucci JC; Trelle MB; McClintock CS; Qureshi T; Jørgensen TJ; Peterson CB Biochemistry; 2016 Aug; 55(31):4386-98. PubMed ID: 27416303 [TBL] [Abstract][Full Text] [Related]
9. Serpin latency transition at atomic resolution. Cazzolli G; Wang F; a Beccara S; Gershenson A; Faccioli P; Wintrode PL Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15414-9. PubMed ID: 25313058 [TBL] [Abstract][Full Text] [Related]
10. Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved. Jendroszek A; Sønnichsen MS; Muñoz AC; Leyman K; Christensen A; Petersen SV; Wang T; Bendixen C; Panitz F; Andreasen PA; Jensen JK Thromb Haemost; 2017 Aug; 117(9):1688-1699. PubMed ID: 28771275 [TBL] [Abstract][Full Text] [Related]
11. Specific interactions of serpins in their native forms attenuate their conformational transitions. Na YR; Im H Protein Sci; 2007 Aug; 16(8):1659-66. PubMed ID: 17600149 [TBL] [Abstract][Full Text] [Related]
12. Latency and substrate binding globally reduce solvent accessibility of plasminogen activator inhibitor type 1 (PAI-1). An adaptation of PAI-1 conformer crystal structures by hydrogen-deuterium exchange. Nukuna BN; Penn MS; Anderson VE; Hazen SL J Biol Chem; 2004 Nov; 279(48):50132-41. PubMed ID: 15337743 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation. Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421 [TBL] [Abstract][Full Text] [Related]
14. Probing nanosecond motions of plasminogen activator inhibitor-1 by time-resolved fluorescence anisotropy. Ko CW; Wei Z; Marsh RJ; Armoogum DA; Nicolaou N; Bain AJ; Zhou A; Ying L Mol Biosyst; 2009 Sep; 5(9):1025-31. PubMed ID: 19668868 [TBL] [Abstract][Full Text] [Related]
15. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop. Gils A; Knockaert I; Declerck PJ Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525 [TBL] [Abstract][Full Text] [Related]
16. The conformational dynamics of a metastable serpin studied by hydrogen exchange and mass spectrometry. Tsutsui Y; Liu L; Gershenson A; Wintrode PL Biochemistry; 2006 May; 45(21):6561-9. PubMed ID: 16716066 [TBL] [Abstract][Full Text] [Related]
17. Extending the capabilities of targeted molecular dynamics: simulation of a large conformational transition in plasminogen activator inhibitor 1. Krüger P; Verheyden S; Declerck PJ; Engelborghs Y Protein Sci; 2001 Apr; 10(4):798-808. PubMed ID: 11274471 [TBL] [Abstract][Full Text] [Related]
18. Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix F. Schousboe SL; Egelund R; Kirkegaard T; Preissner KT; Rodenburg KW; Andreasen PA Thromb Haemost; 2000 May; 83(5):742-51. PubMed ID: 10823273 [TBL] [Abstract][Full Text] [Related]
19. Measuring the hydrogen/deuterium exchange of proteins at high spatial resolution by mass spectrometry: overcoming gas-phase hydrogen/deuterium scrambling. Rand KD; Zehl M; Jørgensen TJ Acc Chem Res; 2014 Oct; 47(10):3018-27. PubMed ID: 25171396 [TBL] [Abstract][Full Text] [Related]
20. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop. Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]